Predict your next investment

INDUSTRIAL | Basic Materials / Specialty Chemicals

See what CB Insights has to offer

Founded Year



Acquired | Acquired

About Orkila

Orkila distributes specialty chemicals throughout Africa and the Middle East.

Orkila Headquarter Location

Rive Gauche Tower, 22nd floor




Latest Orkila News

Cannamedical Receives €15M Equity Investment from Orkila Capital

Jan 31, 2019

US- and Germany-based Orkila Capital made a minority equity investment in the company. Founded in 2016 by David Henn, CEO, Cannamedical Pharma imports medical cannabis products and distribute them to around 2,000 pharmacies and clinical facilities to help doctors, healthcare professionals and pharmacists improve the quality of their patients’ lives. Its products are focused on people with cancer, multiple sclerosis (MS) and chronic or acute pain. The company, which started operating following the legalization of medical cannabis in Germany in March 2017, employs around 40 people in Cologne and generates a million turnover. It also has subsidiaries in Canada, the United Kingdom and Greece. Following the investment, founder David Henn holds approximately 60% of the shares in the company with SN-Invests, a Luxembourg-based start-up investor, being the third largest shareholder with a stake of almost 21%. FinSMEs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.